Mirvaso 5 mg/g (Brimonidine Tartrate GEL) 5 mg/g

Mirvaso 5 mg/g gel is a topical medication containing brimonidine tartrate, used for managing facial redness. This prescription-strength treatment is designed for external application and is manufactured by Galderma Laboratories, L.P.

Strength

5 mg/g

Pack Size

2 g in 1 TUBE (0299-5980-02)

Manufacturer / TM Owner

Galderma Laboratories, L.P.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mirvaso 5 mg/g gel is primarily used to reduce facial redness associated with rosacea. The active ingredient, brimonidine tartrate, works by constricting blood vessels in the skin, which can help alleviate visible redness. This topical treatment is applied directly to the affected areas of the face. People often ask, 'What is Mirvaso used for?' and the answer is that it is specifically formulated to address persistent facial redness.

Side Effects

When applied as directed, Mirvaso 5 mg/g gel may help reduce the appearance of facial redness. Some users report a noticeable improvement in their skin's appearance within a short period. However, individual results can vary, and it's important to follow the prescribed usage guidelines for the best outcomes.

Precautions & Warnings

Mirvaso 5 mg/g gel is intended for external use only. Avoid contact with the eyes, mouth, and other mucous membranes. It is important to follow the instructions provided by your healthcare professional. If you experience any adverse reactions, discontinue use and consult a healthcare provider.

Avoid Interactions

Mirvaso 5 mg/g gel may interact with other topical medications or skincare products. It is advisable to inform your healthcare provider about all the products you are currently using. Additionally, avoid using this gel in combination with other strong vasoconstrictors without medical supervision.

Frequently Asked Questions

Mirvaso 5 mg/g gel is used to reduce facial redness associated with rosacea.

Apply a thin layer of Mirvaso gel to the affected areas of the face as directed by your healthcare provider.

It is advisable to consult your healthcare provider before combining Mirvaso gel with other skincare products.

If you experience any adverse reactions, discontinue use and consult your healthcare provider.

Mirvaso gel is generally safe for most skin types, but individual reactions can vary.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.